| 8247448 |
Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes |
Jean-Jacques Zeiller, Herve Dumas, Valérie Guyard-Dangremont, Isabelle Berard, Francis Contard +2 more |
2012-08-21 |
$165,154,000 |
| 8063067 |
Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof |
Jean-Jacques Zeiller, Herve Dumas, Valérie Guyard-Dangremont, Isabelle Berard, Francis Contard +2 more |
2011-11-22 |
$79,793,000 |
| 7820847 |
Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them and use for the treatment of dyslipidaemia, atherosclerosis and diabetes |
Jean-Jacques Zeiller, Herve Dumas, Valérie Guyard-Dangremont, Isabelle Berard, Francis Contard +2 more |
2010-10-26 |
$63,961,000 |
| 7737176 |
Substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them |
Michel Brunet, Jean-Jacques Zeiller, Gerard Ferrand |
2010-06-15 |
$117,285,000 |
| 7691628 |
Use of Rev-erb family of receptors in screening |
Eric Raspe |
2010-04-06 |
$50,617,000 |
| 7678831 |
Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof |
Jean-Jacques Zeiller, Herve Dumas, Valérie Guyard-Dangremont, Isabelle Berard, Francis Contard +2 more |
2010-03-16 |
$69,781,000 |
| 7632846 |
Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof |
Jean-Jacques Zeiller, Herve Dumas, Valérie Guyard-Dangremont, Isabelle Berard, Francis Contard +2 more |
2009-12-15 |
$106,751,000 |
| 7482484 |
Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia |
Nathalie Adje, Michel Brunet, Didier Roche, Jean-Jacques Zeiller, Stéphane Yvon +4 more |
2009-01-27 |
$37,804,000 |
| 7465752 |
Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof |
Jean-Jacques Zeiller, Herve Dumas, Valérie Guyard-Dangremont, Isabelle Berard, Francis Contard +2 more |
2008-12-16 |
$69,697,000 |
| 6998254 |
Use of ROR for receptors for screening substances useful for the treatment of atherosclerosis |
Eric Raspe |
2006-02-14 |
$52,408,000 |
| RE38629 |
Solid oral dosage form comprising a combination of metformin and glibenclamide |
Geoffrey Nicholson, Gillian Cave, Sarah J. Nicholson |
2004-10-19 |
|
| 6512009 |
Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator |
Martine Daoust, Philippe Durbin |
2003-01-28 |
|
| 6372790 |
Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia |
Philippe Briet |
2002-04-16 |
$103,856,000 |
| 6303146 |
Solid oral dosage form comprising a combination of metformin and glibenclamide |
Geoffrey Nicholson, Gillian Cave, Sarah J. Nicholson |
2001-10-16 |
|
| 5834448 |
Dosage form of hydroxocobalamin and its use in cyanide poisoning |
Gerard Pouchol, Marie-Laure Poulain, Michel Duran |
1998-11-10 |
$144,493,000 |
